Publications by authors named "Martin Feuring"

Claim this Profile
I
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.
Dipak Kotecha, Günter Breithardt, A John Camm, Gregory Y H Lip, Ulrich Schotten, Martin Feuring

Europace· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.
Samuel Z Goldhaber, Sam Schulman, Henry Eriksson, Martin Feuring, Mandy Fraessdorf

Thromb Haemost· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER, RE-COVER™ II, and RE-MEDY™.
Martin Feuring, Sam Schulman, Henry Eriksson, Ajay J Kakkar, Sebastian Schellong

J Thromb Thrombolysis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Samuel Z Goldhaber, Henry Eriksson, Ajay Kakkar, Sebastian Schellong, Martin Feuring

Vasc Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II.
Samuel Z Goldhaber, Sebastian Schellong, Ajay Kakkar, Henry Eriksson, Martin Feuring

Thromb Haemost· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery.
Bengt I Eriksson, Zsolt Mikuska, Martin Feuring, Jean Amiral, Sebastian Haertter

Thromb Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of dabigatran etexilate for the treatment of venous thrombosis.
Martin Feuring, Joanne van Ryn

Expert Opin Drug Discov· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study of dabigatran etexilate 150mg in patients with moderate renal impairment undergoing elective total hip or knee replacement.
Charles-Marc Samama, Nadia Rosencher, Eva Kleine, Martin Feuring, Martina Brueckmann

Thromb Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events.
Ammar Majeed, Hun-Gyu Hwang, John W Eikelboom, Stuart Connolly, Lars Wallentin, Martin Feuring

Thromb Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting.
Nadia Rosencher, Charles M Samama, Martin Feuring, Martina Brueckmann, Eva Kleine

Thromb J· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism.
Ammar Majeed, Samuel Z Goldhaber, Ajay Kakkar, Clive Kearon, Henry Eriksson, Martin Feuring

Thromb Haemost· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials.
Bengt I Eriksson, Ola E Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel, Martin Feuring

Thromb J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery.
Christian Wurnig, Andreas Clemens, Helmuth Rauscher, Eva Kleine, Martin Feuring

Thromb J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
Sam Schulman, Samuel Z Goldhaber, Clive Kearon, Ajay K Kakkar, Sebastian Schellong, Martin Feuring

Thromb Haemost· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management.
Bastian Hass, Jayne Pooley, Adrian E Harrington, Andreas Clemens, Martin Feuring

Thromb J· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Bengt I Eriksson, Ola E Dahl, Martin Feuring, Andreas Clemens, Herbert Noack

Thromb Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.
Bengt I Eriksson, John J Smith, Joseph Caprini, Stefan Hantel, Andreas Clemens, Martin Feuring

Thromb Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.
Nadia Rosencher, Herbert Noack, Martin Feuring, Andreas Clemens, Richard J Friedman

Thromb J· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.
Andreas Clemens, Joanne van Ryn, Regina Sennewald, Norio Yamamura, Joachim Stangier, Martin Feuring

Eur J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health technology assessment and its role in the future development of the Indian healthcare sector.
Bastian Hass, Jayne Pooley, Martin Feuring, Viraj Suvarna, Adrian E Harrington

Perspect Clin Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran.
Joachim Stangier, Martin Feuring

Blood Coagul Fibrinolysis· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.
Martin Feuring, Martin Wehling, Armin Schultz

Clin Exp Pharmacol Physiol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
Joanne van Ryn, Joachim Stangier, Sebastian Haertter, Karl-Heinz Liesenfeld, Wolfgang Wienen, Martin Feuring

Thromb Haemost· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive age.
Per Otto Schueller, Martin Feuring, Yulia Sharkova, Wolfram Grimm, Michael Christ

Int J Cardiol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100.
Martin Feuring, Armin Schultz, Ralf Losel, Martin Wehling

Semin Thromb Hemost· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis